SAINT-REMY JEAN-MARIE has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are BODE GENE DEV CO LTD SHANGHAI, SHANGHAI BIOWINDOW GENE DEV and BIOWINDOW GENE DEV INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Foods and drinks | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Animal care | |
#6 | Enzymes | |
#7 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Saint-Remy Jean-Marie | 14 |
#2 | Jacquemin Marc | 3 |
Publication | Filing date | Title |
---|---|---|
US2011010786A1 | Transgenic animal expressing b cell antigen receptor |